Cargando…
Nonsteroidal Anti-Inflammatory Drugs in Viral Infections Disease, Specially COVID-19
During the current SARS-CoV-2 (COVID-19) pandemic, some reports were presented based on those nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids may exacerbate symptoms in COVID-19 patients. According to this, we aimed to collate information available in published articles to identify...
Autores principales: | Chamkouri, Narges, Absalan, Forouzan, Koolivand, Zahra, Yousefi, Mahsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012024/ https://www.ncbi.nlm.nih.gov/pubmed/36926440 http://dx.doi.org/10.4103/abr.abr_148_21 |
Ejemplares similares
-
Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19
por: Ricciotti, Emanuela, et al.
Publicado: (2021) -
Nonsteroidal Anti-Inflammatory Drugs and the Kidney
por: Hörl, Walter H.
Publicado: (2010) -
Nonsteroidal anti‐inflammatory drugs and pharyngitis
por: Mazzone, Stuart B, et al.
Publicado: (2022) -
Topical nonsteroidal anti-inflammatory drugs
por: Bhat, Chirag, et al.
Publicado: (2023) -
Nonsteroidal anti‐inflammatory drugs in acute viral respiratory tract infections: An updated systematic review
por: Azh, Nima, et al.
Publicado: (2022)